Showing results (71-80 of 156) with videos related to

Sort By:
Pageof 16
American Journal of Hematology|April 23, 2009
Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphomaChitra Hosing, Rima M Saliba, Sheena Ahlawat, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 3, 2004
Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantationDaniel R Couriel, Rima M Saliba, Sergio Giralt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2019
Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning RegimensHossein Maymani, Paul Lin, Rima M Saliba, et al.
Bone Marrow Transplantation|August 26, 2024
Gastrointestinal involvement refines prognosis in minnesota standard risk acute graft-vs.-host diseaseCurtis M Marcoux, Amin M Alousi, Jin Im, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fractionMuzaffar H Qazilbash, Ali Imran Amjad, Suhail Qureshi, et al.
Bone Marrow Transplantation|March 23, 2011
Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CRU Popat, M J de Lima, R M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 9, 2010
Resolved hepatitis B virus infection is not associated with worse outcome after allogeneic hematopoietic stem cell transplantationCarlos A Ramos, Rima M Saliba, Leandro de Pádua Silva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2008
High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of ageC Hosing, R M Saliba, G-J Okoroji, et al.
Pageof 16